🔗 Share this article

Acclaimed soul vocalist D’Angelo passed away on October 14 at age 51 after a personal fight with pancreatic malignancy.

“The brilliant light of our family has faded away for us in the present world,” his relatives stated. “After a lengthy and courageous battle with cancer, we are heartbroken to declare that D’Angelo, known to his followers around the globe as D’Angelo, has been called home.”

D’Angelo left an indelible mark on the music industry with his innovative neo-soul sound and collaborations with renowned musicians.

He released his debut album, “Brown Sugar,” in the mid-nineties to immediate acclaim. The record reached No. 4 on the R&B charts, earned platinum status soon after, and earned multiple Grammy nominations.

However, it was his second album, “Voodoo,” in 2000 that boosted his music career into the limelight. The album debuted at the top spot on both the R&B charts and the Billboard 200. He won two Grammys: Top R&B Record and Outstanding Male Vocal Performance for “Untitled (How Does It Feel).”

The music video for “Untitled (How Does It Feel)” cemented D’Angelo’s standing as a icon, albeit a hesitant one, in the public consciousness. The personal depiction featured the singer, notably bare to his midsection, singing directly into the camera.

D’Angelo stepped back from the spotlight after releasing Voodoo and openly battled with drugs and alcohol. In 2005, he was involved in a severe car crash that left him in critical condition.

Over ten years later, his third and final album, “Black Messiah” (2014), confirmed his enduring appeal with a further No. 1 debut on the soul music rankings and a Grammy for Top R&B Record.

Again, in his own mysterious fashion, D’Angelo made only a few public appearances in the subsequent period.

The singer was announced as a top act for the 2025 music event, but his appearance was called off, due to an “unexpected health issue.”

Even though information is limited about D’Angelo’s well-being in the weeks before his passing, he had reportedly been in the hospital for months and in palliative care for a fortnight.

D’Angelo’s passing is a clear example of the harmful impact of pancreatic malignancy, one of the deadliest and least preventable types of the disease, on a brilliant talent whose life was ended too soon.

“We are grieved that he can only provide dear memories with his family, but we are forever thankful for the heritage of extraordinarily moving songs he has left us,” his family said.

Pancreatic Malignancy: Deadly and Rarely Preventable

Pancreatic cancer affects the digestive organ, a small organ that produces insulin and plays an essential role in breaking down food, among additional roles. The size and location of the pancreas in the human system make it more difficult to detect cancer.

Although pancreatic cancer accounts for only about 3% of cancer diagnoses annually in the United States, it is causes 7% of malignancy fatalities.

Almost seventy thousand people will be found to have this condition and about 52,000 will succumb to the disease in 2025.

“Pancreatic cancer is one of the deadliest cancers, with an aggressive tumor and poor prognosis. We have few and poor therapies, and a smaller window to make a significant difference on the lives of patients,” said a medical oncologist.

Because pancreatic cancer seldom produces early symptoms, it’s frequently diagnosed only once the condition is advanced. Although a patient has symptoms they are usually nonspecific and may be confused with a number of everyday ailments.

“Currently, there is no good way to identify pancreatic cancer in the early stages, except for listening to your body and speaking with your doctor if there are unfamiliar signs,” explained a health expert.

Common symptoms of this disease encompass:

• abdominal or lower back pain
• reduced body mass
• jaundice
• loss of appetite
• dark urine
• pale or fatty bowel movements
• loose stools
• excessive hunger or thirst
• nausea

At age 51, D’Angelo’s demise is an exception, as this malignancy is most common in individuals in the sixty-five to seventy-five age bracket. However, many cancers, such as pancreatic cancer, have become increasingly prevalent in younger people.

“This disease identified before the age of 50 is deemed uncommon, yet concerningly, doctors are noticing a rising count of younger patients suffering from this condition,” said a specialist.

Family History Affects Cancer Risk

Without reliable screening tools for this malignancy, professionals emphasized the significance of understanding your family’s health background. Some risk factors, such as tobacco use and excess weight also play a role in the onset of this disease.

African Americans have the greatest occurrence of this malignancy in the U.S. and are more prone to be found to have inoperable cancer.

“The initial action toward lowering one’s risk of pancreatic cancer is understanding individual susceptibility. Individuals should examine their family history, genetic background, and medical conditions, such as blood sugar disease, long-term pancreas inflammation, or obesity that may raise their vulnerability,” said a medical professional.

Hereditary elements are linked to as much as 10% of all this malignancy instances. If a relative in your household has had pancreatic cancer, you may want to consider genetic testing.

“For individuals with a relative’s background of this condition or those carrying high risk genetic mutations, screening may involve advanced imaging such as MRI scans or endoscopic ultrasound (EUS) to find early changes in the pancreas,” he explained.

For those looking to lower their chance, habit adjustments may have an effect. The best action you can take to lower your risk of pancreatic cancer is to stop tobacco use, and if you are a non-smoker, stay away altogether.

Heavy alcohol consumption is associated with pancreas inflammation, a contributing element for this malignancy, so limiting or abstaining from drinks may assist lower your chance.

Controlling your body mass or losing weight may also help decrease your susceptibility. People with excess weight are 20% more likely to get this disease. This malignancy also occurs more often in those with blood sugar issues, and weight loss can also lower the risk of type 2 diabetes.

In spite of pancreatic cancer’s poor prognosis, there is reason for optimism.

“We are making progress with therapies and newer mixed drug treatments. There are developing precision medicines that are already making an impact,” said a expert.

For many individuals, however, awareness about this rare but {dev